摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2'-d-3'AMPS | 211733-54-9

中文名称
——
中文别名
——
英文名称
2'-d-3'AMPS
英文别名
2'-deoxyadenosine-3'-O-thiophosphate;Deoxyadenosine-3'-monophosphate;[(2R,3S,5R)-5-(6-aminopurin-9-yl)-3-dihydroxyphosphinothioyloxyoxolan-2-yl]methanol
2'-d-3'AMPS化学式
CAS
211733-54-9
化学式
C10H14N5O5PS
mdl
——
分子量
347.291
InChiKey
IRBPYDHRSOWSOS-RRKCRQDMSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    678.6±65.0 °C(Predicted)
  • 密度:
    2.12±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -0.3
  • 重原子数:
    22
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    181
  • 氢给体数:
    4
  • 氢受体数:
    10

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    参考文献:
    名称:
    Synthesis of Nucleoside 3′-Thiophosphates in One Step Procedure
    摘要:
    A mild and efficient one-step method of thiophosphorylation was devised for acid-sensitive nucleosides. The procedure is based on thiophosphorylation of nucleoside magnesium alkoxide by 2-chloro-2-thio-1,3,2-dioxaphospholane. The utility and efficiency of this method combined with deprotection of the resulting cyclic triester were demonstrated by its application to the synthesis of both adenosine 3'- and 5'-thiophosphates. The procedure does not require protection of the exocyclic amino group and can be successfully used for the thiophosphorylation of nucleosides that are unusually sensitive to depurination.
    DOI:
    10.1080/15257779908041610
点击查看最新优质反应信息

文献信息

  • COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE LECT2 GENE
    申请人:ALNYLAM PHARMACEUTICALS, INC.
    公开号:US20180135057A1
    公开(公告)日:2018-05-17
    The invention relates to antisense polynucleotide agents targeting the LECT2 gene, and methods of using such antisense polynucleotide agents to inhibit expression of LECT2 and to treat subjects having a LECT2-associated disease, e.g., amyloidosis.
    这项发明涉及针对LECT2基因的反义多核苷酸药剂,以及利用这种反义多核苷酸药剂抑制LECT2表达并治疗患有LECT2相关疾病(例如淀粉样变性)的受试者的方法。
  • An Efficient Reagent for the Phosphorylation of Deoxyribonucleosides, DNA Oligonucleotides, and Their Thermolytic Analogues
    作者:Cristina Ausín、Andrzej Grajkowski、Jacek Cieślak、Serge L. Beaucage
    DOI:10.1021/ol0516263
    日期:2005.9.1
    and demonstrated efficiency in the synthesis of conventional 5'-/3'-phosphate/thiophosphate monoester derivatives of 2'-deoxyribonucleosides and DNA oligonucleotides. Moreover, the use of 11 has enabled the preparation of the dinucleoside phosphorothioate analogue 26 in high yields (>95%) with minimal cleavage (<2%) of the thermolytic thiophosphate protecting group.
    [反应:见正文]从2巯基乙酸甲酯分三步制备亚磷酰胺11,并证明了2'-脱氧核糖核苷的常规5'-/ 3'-磷酸酯/硫代磷酸酯单酯衍生物和DNA寡核苷酸的合成效率。而且,使用11使得能够以高收率(> 95%)制备二核苷硫代磷酸酯类似物26,而热解硫代磷酸酯保护基团的裂解最小(<2%)。
  • Compositions and methods for inhibiting expression of the LECT2 gene
    申请人:ALNYLAM PHARMACEUTICALS, INC.
    公开号:US10077444B2
    公开(公告)日:2018-09-18
    The invention relates to double-stranded ribonucleic acid (dsRNA) compositions targeting the LECT2 gene, and methods of using such dsRNA compositions to alter (e.g., inhibit) expression of LECT2.
    本发明涉及靶向 LECT2 基因的双链核糖核酸(dsRNA)组合物,以及使用这种 dsRNA 组合物改变(例如抑制)LECT2 表达的方法。
  • Compositions and methods for inhibiting expression of the ALAS1 gene
    申请人:ALNYLAM PHARMACEUTICALS, INC.
    公开号:US10119143B2
    公开(公告)日:2018-11-06
    The invention relates to double-stranded ribonucleic acid (dsRNA) compositions targeting the ALAS1 gene, and methods of using such dsRNA compositions to alter (e.g., inhibit) expression of ALAS1.
    本发明涉及靶向 ALAS1 基因的双链核糖核酸(dsRNA)组合物,以及使用这种 dsRNA 组合物改变(如抑制)ALAS1 表达的方法。
  • Polynucleotide agents targeting Serpinc1 (AT3) and methods of use thereof
    申请人:Genzyme Corporation
    公开号:US10344278B2
    公开(公告)日:2019-07-09
    The invention relates to polynucleotide agents targeting the Serpinc1 (AT3) gene, and methods of using such polynucleotide agents to inhibit expression of Serpinc1 and to treat subjects having a bleeding disorder, e.g., a hemophilia.
    本发明涉及靶向Serpinc1(AT3)基因的多核苷酸制剂,以及使用这种多核苷酸制剂抑制Serpinc1的表达和治疗出血性疾病(如血友病)患者的方法。
查看更多